Target intelligence / Profile preview

DDB1 and CUL4 associated factor 13 pseudogene 2 (DCAF13P2)

Target: DCAF13P2
Molecular classification: Other

Overview

DDB1 and CUL4 associated factor 13 pseudogene 2 (DCAF13P2) is classified as a pseudogene related to DCAF13, a gene encoding a substrate recognition component of the cullin RING E3 ubiquitin ligase complex involved in cell cycle progression, oocyte development, and cancer biology[1][2]. However, DCAF13P2 itself does not encode a functional protein, has no established biological or therapeutic roles, and is not recognized as a molecular target for drug discovery[1][2]. Most functional studies and disease associations are with DCAF13, not this pseudogene.

Other names: DDB1 and CUL4 associated factor 13 pseudogene 2DCAF13P2

Beyond the preview

Go deeper on DDB1 and CUL4 associated factor 13 pseudogene 2 (DCAF13P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDB1 and CUL4 associated factor 13 pseudogene 2 (DCAF13P2).

Explore the full profile